-
Product Insights
Bacillary Dysentery (Shigellosis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Bacillary Dysentery (Shigellosis) Global Clinical Trials Review, H2, 2018" provides an overview of Bacillary Dysentery (Shigellosis) clinical trials scenario. This report provides top line data relating to the clinical trials on Bacillary Dysentery (Shigellosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2018" provides an overview of Skin And Skin Structure Infections (SSSI) clinical trials scenario. This report provides top line data relating to the clinical trials on Skin And Skin Structure Infections (SSSI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2018" provides an overview of Skin And Skin Structure Infections (SSSI) Caused By Bacteria clinical trials scenario. This report provides top line data relating to the clinical trials on Skin And Skin Structure Infections (SSSI) Caused By Bacteria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease...
-
Product Insights
Smallpox Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Smallpox Global Clinical Trials Review, H2, 2018" provides an overview of Smallpox clinical trials scenario. This report provides top line data relating to the clinical trials on Smallpox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Pneumococcal Vaccines - Epidemiology Forecast to 2028
Streptococcus pneumoniae (S. pneumoniae) is a bacterial organism that causes a number of diseases, ranging from serious to mild infections. Symptoms depend on the part of the body that is infected, and range from fever, chills, and difficulty breathing to stiff neck and confusion. Transmission of S. pneumoniae primarily occurs through respiratory droplets. The term invasive pneumococcal disease (IPD) refers to more severe infections in which the bacterium is isolated from normally sterile sites. IPD is most common in high-risk...
-
Sector Analysis
Seasonal Influenza Vaccines - Epidemiology Forecast in Asia-Pacific Markets to 2028
Seasonal influenza is a contagious respiratory viral illness. There are four types of seasonal influenza viruses (A, B, C, and D); however, only types A and B cause human disease of public health concern. Influenza transmission occurs when people with flu cough, sneeze, or talk and disseminate droplets. These droplets can land in the mouths or noses of people who then inhale them into the lungs. GlobalData epidemiologists identified country-specific population-based studies published in peer-reviewed journal articles and government-collated surveillance...
-
Sector Analysis
Seasonal Influenza Vaccines - Forecast in Asia-Pacific Markets to 2028
Seasonal influenza is a viral infection that occurs annually in the winter months from December to March/April in the Northern Hemisphere and from May to August/September in the Southern Hemisphere, though most of India follows Southern Hemisphere seasonality Two types of influenza virus, type A and B, are responsible for the majority of seasonal influenza infections in humans, and due to frequent virus mutations annual vaccination is recommended. The WHO estimates three to five million cases of severe seasonal influenza...
-
Product Insights
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The bacterial vaginosis clinical trial market research report provides an overview of the bacterial vaginosis clinical trials scenario. The report provides top line data relating to the clinical trials on bacterial vaginosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Pyelonephritis Disease - Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2019" provides an overview of Pyelonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Pyelonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Leishmaniasis (Kala-Azar) clinical trial market research report provides an overview and top-line data relating to the clinical trials on Leishmaniasis. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.